Healthcare Advisory Services President Joins Covalon Technologies’ Board of Directors

Covalon Technologies Ltd., an advanced medical technologies company, has appointed Dr. Myrna Francis to its Board of Directors.
 
Dr. Francis has an extensive background in healthcare and is well-known in both private and public sectors; her experience spans the international marketplace—Canada, the United States, and Europe. She is currently the president of Mfran Healthcare Advisory Services. She is the vice chair of OCAD University’s Board of Governors and serves as a board director at Medavie Inc. and as a volunteer advisor for BioMedical Zone and MaRS Discovery District, Health Ventures Group. Dr. Francis has previously held positions as the CEO of Canada Health Infoway, vice president, Global Healthcare Sector, at CGI Group Inc., Partner at CSC Healthcare Group, and numerous executive positions with the Ontario Ministry of Health. She has also served as a board director for a variety of companies and organizations, including RxCanada, Allstate Insurance Company of Canada, and Cedara Software Corp. She currently provides strategic advisory services in the public sector and to multinational private sector companies regarding health information technology, business transformation, business and product growth strategies, and innovation as an independent consultant.

“Covalon is delighted to have someone of Dr. Francis’ experience join our Board of Directors,” said Brian Pedlar, CEO. “Dr. Francis has significant experience in the healthcare industry and with both public and private boards, developed during her career. The Covalon management team and board are looking forward to benefiting from Dr. Francis’ contribution as an independent board member.”

Dr. Francis earned a master’s degree in psychology and Ph.D. in medical sciences, both from McMaster University, and a Multi-Party Negotiations Certification from Harvard Law School.
 
“I am looking forward to serving on Covalon’s Board of Directors,” said Dr. Francis. “I am familiar with Covalon’s management from my time as a director at Cedara Software and have watched Covalon grow over the last few years. I am excited to participate in the guidance of this company.”
 
Dr. Francis’ appointment to Covalon’s Board of Directors is subject to TSX approval.

Covalon Technologies Ltd. researches, develops, and commercializes new healthcare technologies. Covalon’s patented technologies, products, and services address the advanced healthcare needs of medical device companies, healthcare providers, and individual consumers. Covalon’s technologies are used to prevent, detect, and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care, and medical device coatings.